{"slideshow_credits": null, "snippet": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "abstract": "Food and Drug Administration approves two new skin cancer drugs from Bristol-Myers Squibb; drugs Opdivo and Yervoy work by bolstering immune system.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/10/02/business/fda-approves-combining-2-cancer-fighting-drugs.html", "lead_paragraph": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "headline": {"print_headline": "Fda Approves Combining Two Cancer-Fighting Drugs ", "main": "F.D.A. Approves Combining 2 Cancer-Fighting Drugs", "content_kicker": "Business Briefing", "kicker": "Business Briefing"}, "_id": "560dcddc38f0d81aa77a5214", "word_count": "138", "multimedia": [], "pub_date": "2015-10-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Bristol Myers Squibb Company", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Skin Cancer", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Melanomas", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}